Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic

被引:43
|
作者
Ho, M. W. [1 ]
Field, E. A. [4 ]
Field, J. K. [2 ,4 ]
Risk, J. M. [2 ]
Rajlawat, B. P. [4 ]
Rogers, S. N. [1 ,5 ]
Steele, J. C. [4 ]
Triantafyllou, A. [2 ,3 ]
Woolgar, J. A. [2 ,3 ]
Lowe, D. [5 ]
Shaw, R. J. [1 ,2 ]
机构
[1] Aintree Univ Hosp NHS Fdn Trust, Reg Maxillofacial Unit, Liverpool L9 7AL, Merseyside, England
[2] Univ Liverpool, Sch Canc Studies, Liverpool L69 3BX, Merseyside, England
[3] NHS Fdn Trust, Univ Hosp Aintree, Dept Oral Pathol, Liverpool L9 7AL, Merseyside, England
[4] Univ Liverpool, Dent Hosp, Dept Oral Med, Liverpool L69 3BX, Merseyside, England
[5] Edge Hill Univ, Fac Hlth, Evidence Based Practice Res Ctr EPRC, Ormskirk, Lancs, England
关键词
Oral dysplasia; Oral cancer; Malignant transformation; Survival oral cancer; Treatment oral cancer; Potentially malignant oral lesion; Recurrence oral cancer; Recurrence oral dysplasia; Laser oral cancer; OF-LIFE QUESTIONNAIRE; MALIGNANT-TRANSFORMATION; PRIMARY SURGERY; CANCER; DELAY;
D O I
10.1016/j.bjoms.2013.03.014
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Surveillance of oral epithelial dysplasia results in a number of newly diagnosed cases of oral squamous cell carcinoma (SCC). The clinical stage of oral SCC at diagnosis influences the magnitude of treatment required and the prognosis. We aimed to document the stage, treatment, and outcome of oral SCC that arose in patients who were being monitored for oral epithelial dysplasia in a dedicated multidisciplinary clinic. Those with histologically diagnosed lesions were enrolled on an ethically approved protocol and molecular biomarker study. Details of clinical and pathological TNM, operation, radiotherapy, recurrence, second primary tumour, and prognosis, were recorded in patients whose lesions underwent malignant transformation. Of the 91 patients reviewed (median follow-up 48 months, IQR 18-96), 23 (25%) had malignant transformation. All were presented to the multidisciplinary team with stage 1 disease (cT1N0M0). Of these, 21 were initially treated by wide local excision, 2 required resection of tumour and reconstruction, and 2 required adjuvant radiotherapy. At follow-up 3 had local recurrence, one had regional recurrence, one had metachronous lung cancer, and 5 had second primary oral SCC. There were further diagnoses of oral dysplasia in 5 during follow-up, and it is estimated that 76% of patients will have one or other event in 5 years. Disease-specific survival was 100% and overall survival was 96% (22/23). Median follow-up after diagnosis of oral SCC was 24 months (IQR 11-58). Specialist monitoring of oral epithelial dysplasia by a multidisciplinary team allows oral SCC to be detected at an early stage, and enables largely curative treatment with simple and usually minor surgical intervention. The high incidence of second primary oral SCC in high-risk patients with oral epithelial dysplasia further supports intensive targeted surveillance in this group. (C) 2013 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:594 / 599
页数:6
相关论文
共 50 条
  • [31] The prevalence of oral squamous cell carcinoma with oral submucous fibrosis
    Saalim, Mohd
    Sansare, Kaustubh
    Karjodkar, Freny R.
    Johaley, Satyapal
    Ali, Ibrahim K.
    Sharma, Sneha R.
    Mehra, Archana
    Rahman, Bushra
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (06) : 1510 - 1514
  • [32] Evaluation of Cytotoxic T Lymphocytes and Natural Killer Cell Distribution in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia: An Immunohistochemical Study
    John, Sneha
    Joseph, Anna P.
    Pillai, Varun B. Raghavan
    Ramani, Pratibha
    Jayanthi, P.
    Ramalingam, Karthikeyan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [33] Evaluation of immunohistochemical expression of TWIST in oral epithelial dysplasia and squamous cell carcinoma
    Qahtani, Mashael S.
    El-Deeb, Amal M.
    Metwaly, Hamdy A. M.
    INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS, 2020, 14 (02): : 33 - 39
  • [34] Different Expression of Aldehyde Dehydrogenases 1A1 and 2 in Oral Leukoplakia With Epithelial Dysplasia and in Oral Squamous Cell Carcinoma
    Costa, Fernanda Herrera
    Ribeiro El Achkar, Vivian Narana
    Costa, Victor
    Paladini, Isabela
    Kowalski, Luiz Paulo
    Carvalho, Yasmin Rodarte
    Kaminagakura, Estela
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (07) : 537 - 542
  • [35] Clinical Oral Examinations May Not Be Predictive of Dysplasia or Oral Squamous Cell Carcinoma
    Cleveland, Jennifer L.
    Robison, Valerie A.
    JOURNAL OF EVIDENCE-BASED DENTAL PRACTICE, 2013, 13 (04) : 151 - 154
  • [36] Simultaneous Fluorescence microscopy and spectroscopy of Oral squamous cell carcinoma, Oral dysplasia and normal tissue
    Thapa, Pramila
    Bhatt, Sunil
    Mann, Priyanka
    Nayyar, Vivek
    Mishra, Deepika
    Mehta, Dalip Singh
    TRANSLATIONAL BIOPHOTONICS: DIAGNOSTICS AND THERAPEUTICS III, 2023, 12627
  • [37] ANGIOGENIC SQUAMOUS DYSPLASIA-LIKE PHENOMENON IN ORAL EPITHELIAL PRECURSOR LESIONS
    Siar, C. H.
    Oo, V. P. A.
    Nagatsuka, H.
    Nakano, K.
    Ng, K. H.
    Kawakami, T.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 (07) : 315 - 319
  • [38] Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma
    Chaves, Filipe Nobre
    Marinho Bezerra, Thamara Manoela
    Moraes, Debora Chaves
    dos Santos Costa, Sara Ferreira
    Barros Silva, Paulo Goberlanio
    Negreiros Nunes Alves, Ana Paula
    Gurgel Costa, Fabio Wildson
    Bernardes, Vanessa Fatima
    Alves Pereira, Karuza Maria
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 112
  • [39] Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma
    Johnstone, S.
    Logan, R. M.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 36 (03) : 263 - 266
  • [40] The role of vascular endothelial growth factor (VEGF) in oral dysplasia and oral squamous cell carcinoma
    Johnstone, S
    Logan, RM
    ORAL ONCOLOGY, 2006, 42 (04) : 337 - 342